Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00199095
Status:
COMPLETED
Last Update Posted:
2023-03-20
First Post:
2005-09-12
Brief Title:
Treatment of Elderly Patients 65 Years With Acute Lymphoblastic Leukemia
Sponsor:
Goethe University
Organization:
Goethe University
Study Overview
Official Title:
Pilot Study for Treatment of Elderly Patients 65 Years With Acute Lymphoblastic Leukemia
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia The regimen consists of induction phase I and II followed by cyclic consolidation cycles reinduction and maintenance therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None